Liposomal Bupivacaine No Aid for Intracapsular Femoral Neck Fracture Outcomes
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 8, 2024 -- Liposomal bupivacaine is not associated with significant improvement in postoperative pain or function or hospital length of stay following hip hemiarthroplasty for a femoral neck fracture, according to a study published online Sept. 18 in the Journal of Bone & Joint Surgery.
Kevin K. Kang, M.D., from Maimonides Medical Center in Brooklyn, New York City, and colleagues randomly assigned 50 patients with an isolated intracapsular femoral neck fracture and treated with hip hemiarthroplasty (2018 to 2022) to either intraoperative liposomal bupivacaine and bupivacaine hydrochloride injections or intraoperative bupivacaine hydrochloride injections only.
The researchers observed no significant differences between the groups for average postoperative pain score, total morphine milligram equivalents used postoperatively, and postoperative day of discharge.
"The results of our study suggest that use of liposomal bupivacaine is not associated with substantially improved postoperative pain or function or with a shorter hospital course following hip hemiarthroplasty for a femoral neck fracture," the authors write. "Given the higher cost of liposomal bupivacaine compared with standard postoperative pain modalities, it is worth questioning its use in the setting of geriatric hip fractures."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-09 06:00
Read more
- Scientists Identify Genes That Shape People's Teeth
- Dementia Diagnosis Risk Higher for Stroke Survivors for Up to 20 Years
- In Mouse Studies, New Hope Against a Dangerous Complication of Pregnancy
- Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
- Electronic Sepsis Screening Reduces 90-Day In-Hospital Mortality
- GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions